Cartesian Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	87.23	76.91	106.44	4.74
Short-Term Investments	-	-	28.16	-
Cash & Short-Term Investments	87.23	76.91	134.6	4.74
Cash Growth	-35.20%	-42.86%	2742.70%	-
Accounts Receivable	35.51	8.85	9.76	3.13
Other Receivables	-	-	-	0.23
Receivables	35.51	8.85	9.76	3.35
Prepaid Expenses	2.04	4.97	3.49	0.05
Restricted Cash	-	-	0.29	-
Total Current Assets	124.78	90.73	148.14	8.14
Property, Plant & Equipment	20.52	12.18	14.41	1.5
Long-Term Investments	2	2	2	-
Goodwill	48.16	48.16	-	-
Other Intangible Assets	150.6	150.6	-	-
Other Long-Term Assets	1.67	1.38	1.34	0.03
Total Assets	347.74	305.05	165.89	9.67
Accounts Payable	2.86	3.15	0.32	-
Accrued Expenses	7.74	14.73	14.08	0.79
Current Portion of Long-Term Debt	-	-	8.48	-
Current Portion of Leases	2.52	2.17	1.61	0.17
Current Unearned Revenue	-	2.31	0.59	0.12
Other Current Liabilities	12.99	45.85	-	0.19
Total Current Liabilities	26.12	68.21	25.08	1.27
Long-Term Debt	-	-	17.79	-
Long-Term Leases	12.34	8.79	10.06	1.11
Long-Term Unearned Revenue	-	3.54	-	-
Long-Term Deferred Tax Liabilities	15.85	15.85	-	-
Other Long-Term Liabilities	394.88	348.29	19.14	0.35
Total Liabilities	449.2	444.68	72.06	2.72
Common Stock	0	0.02	0.02	-
Additional Paid-In Capital	560.77	179.05	493.31	6.64
Retained Earnings	-657.64	-614.65	-394.94	-19.61
Comprensive Income & Other	-4.59	-4.6	-4.56	-
Total Common Equity	-101.46	-440.18	93.83	-12.97
Shareholders' Equity	-101.46	-139.63	93.83	6.95
Total Liabilities & Equity	347.74	305.05	165.89	9.67
Total Debt	14.87	10.96	37.93	1.28
Net Cash (Debt)	72.36	65.96	96.68	3.46
Net Cash Growth	-25.15%	-31.78%	2698.18%	-
Net Cash Per Share	8.88	12.76	19.88	0.91
Filing Date Shares Outstanding	21.38	5.4	-	3.81
Total Common Shares Outstanding	17.82	5.4	-	3.81
Working Capital	98.67	22.52	123.06	6.87
Book Value Per Share	-5.69	-81.55	-	-
Tangible Book Value	-300.22	-638.95	93.83	-12.97
Tangible Book Value Per Share	-16.85	-118.38	-	-
Machinery	8.22	7.63	7.34	0.78
Construction In Progress	4.42	0.15	0.6	-
Leasehold Improvements	0.06	0.06	0.06	-

Source: S&P Capital IQ. Standard template. Financial Sources.